STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL • US8585861003

66.78 USD
+0.28 (+0.42%)
At close: Feb 13, 2026
66.78 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, SCL scores 4 out of 10 in our fundamental rating. SCL was compared to 83 industry peers in the Chemicals industry. While SCL is still in line with the averages on profitability rating, there are concerns on its financial health. SCL is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SCL had positive earnings in the past year.
  • SCL had a positive operating cash flow in the past year.
  • In the past 5 years SCL has always been profitable.
  • In the past 5 years SCL always reported a positive cash flow from operatings.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.86%, SCL is in the better half of the industry, outperforming 60.24% of the companies in the same industry.
  • SCL's Return On Equity of 3.63% is fine compared to the rest of the industry. SCL outperforms 61.45% of its industry peers.
  • SCL has a Return On Invested Capital of 3.66%. This is comparable to the rest of the industry: SCL outperforms 54.22% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SCL is in line with the industry average of 6.08%.
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROIC 3.66%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • With a decent Profit Margin value of 1.96%, SCL is doing good in the industry, outperforming 60.24% of the companies in the same industry.
  • SCL's Profit Margin has declined in the last couple of years.
  • SCL has a worse Operating Margin (3.29%) than 65.06% of its industry peers.
  • In the last couple of years the Operating Margin of SCL has declined.
  • Looking at the Gross Margin, with a value of 11.94%, SCL is doing worse than 80.72% of the companies in the same industry.
  • SCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

  • SCL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SCL has been increased compared to 1 year ago.
  • Compared to 5 years ago, SCL has about the same amount of shares outstanding.
  • Compared to 1 year ago, SCL has an improved debt to assets ratio.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • SCL has an Altman-Z score of 2.66. This is not the best score and indicates that SCL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SCL's Altman-Z score of 2.66 is fine compared to the rest of the industry. SCL outperforms 73.49% of its industry peers.
  • SCL has a debt to FCF ratio of 20.43. This is a negative value and a sign of low solvency as SCL would need 20.43 years to pay back of all of its debts.
  • The Debt to FCF ratio of SCL (20.43) is comparable to the rest of the industry.
  • SCL has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • SCL's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. SCL outperforms 78.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Altman-Z 2.66
ROIC/WACC0.3
WACC12.18%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • SCL has a Current Ratio of 1.30. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.30, SCL is not doing good in the industry: 83.13% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.84 indicates that SCL may have some problems paying its short term obligations.
  • The Quick ratio of SCL (0.84) is worse than 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.84
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • SCL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.67%.
  • Measured over the past years, SCL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.51% on average per year.
  • The Revenue has been growing slightly by 5.35% in the past year.
  • The Revenue has been growing slightly by 3.24% on average over the past years.
EPS 1Y (TTM)-18.67%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-53.4%
Revenue 1Y (TTM)5.35%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.94%

3.2 Future

  • Based on estimates for the next years, SCL will show a very strong growth in Earnings Per Share. The EPS will grow by 28.67% on average per year.
  • The Revenue is expected to grow by 6.64% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
EPS Next 5YN/A
Revenue Next Year7.97%
Revenue Next 2Y8.05%
Revenue Next 3Y6.91%
Revenue Next 5Y6.64%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 34.07, the valuation of SCL can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as SCL.
  • Compared to an average S&P500 Price/Earnings ratio of 27.97, SCL is valued a bit more expensive.
  • The Price/Forward Earnings ratio is 18.81, which indicates a rather expensive current valuation of SCL.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SCL.
  • When comparing the Price/Forward Earnings ratio of SCL to the average of the S&P500 Index (27.96), we can say SCL is valued slightly cheaper.
Industry RankSector Rank
PE 34.07
Fwd PE 18.81
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SCL is valued a bit cheaper than 61.45% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SCL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 47.09
EV/EBITDA 10.33
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SCL does not grow enough to justify the current Price/Earnings ratio.
  • SCL's earnings are expected to grow with 28.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)11.11
PEG (5Y)N/A
EPS Next 2Y27.03%
EPS Next 3Y28.67%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.56%, SCL has a reasonable but not impressive dividend return.
  • SCL's Dividend Yield is a higher than the industry average which is at 2.22.
  • SCL's Dividend Yield is a higher than the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

  • On average, the dividend of SCL grows each year by 8.06%, which is quite nice.
  • SCL has paid a dividend for at least 10 years, which is a reliable track record.
  • SCL has decreased its dividend recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 76.82% of the earnings are spent on dividend by SCL. This is not a sustainable payout ratio.
  • The dividend of SCL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP76.82%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (2/13/2026, 8:04:00 PM)

After market: 66.78 0 (0%)

66.78

+0.28 (+0.42%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-29
Earnings (Next)02-23
Inst Owners86.79%
Inst Owner Change0.03%
Ins Owners5.55%
Ins Owner Change9.88%
Market Cap1.51B
Revenue(TTM)2.30B
Net Income(TTM)45.24M
Analysts45
Price Target76.5 (14.56%)
Short Float %1.5%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP76.82%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.76%
Min EPS beat(2)-42.79%
Max EPS beat(2)-22.72%
EPS beat(4)1
Avg EPS beat(4)-24.99%
Min EPS beat(4)-65.06%
Max EPS beat(4)30.63%
EPS beat(8)3
Avg EPS beat(8)-1.9%
EPS beat(12)4
Avg EPS beat(12)-8.59%
EPS beat(16)7
Avg EPS beat(16)-1.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.55%
Revenue beat(4)1
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-3.48%
Revenue beat(16)6
Avg Revenue beat(16)-0.7%
PT rev (1m)-11.76%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 34.07
Fwd PE 18.81
P/S 0.66
P/FCF 47.09
P/OCF 9.67
P/B 1.21
P/tB 1.36
EV/EBITDA 10.33
EPS(TTM)1.96
EY2.94%
EPS(NY)3.55
Fwd EY5.32%
FCF(TTM)1.42
FCFY2.12%
OCF(TTM)6.9
OCFY10.34%
SpS101.85
BVpS55.12
TBVpS48.93
PEG (NY)11.11
PEG (5Y)N/A
Graham Number49.3
Profitability
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROCE 4.4%
ROIC 3.66%
ROICexc 3.93%
ROICexgc 4.3%
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
FCFM 1.39%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
ROICexc(3y)6.06%
ROICexc(5y)8.61%
ROICexgc(3y)6.68%
ROICexgc(5y)9.41%
ROCE(3y)6.76%
ROCE(5y)8.87%
ROICexgc growth 3Y-28.84%
ROICexgc growth 5Y-19.33%
ROICexc growth 3Y-28.18%
ROICexc growth 5Y-20.06%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Debt/EBITDA 1.81
Cap/Depr 101.87%
Cap/Sales 5.39%
Interest Coverage 2.64
Cash Conversion 79.05%
Profit Quality 70.9%
Current Ratio 1.3
Quick Ratio 0.84
Altman-Z 2.66
F-Score5
WACC12.18%
ROIC/WACC0.3
Cap/Depr(3y)225.06%
Cap/Depr(5y)209.82%
Cap/Sales(3y)9.23%
Cap/Sales(5y)8.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.67%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%-53.4%
EPS Next Y3.07%
EPS Next 2Y27.03%
EPS Next 3Y28.67%
EPS Next 5YN/A
Revenue 1Y (TTM)5.35%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.94%
Revenue Next Year7.97%
Revenue Next 2Y8.05%
Revenue Next 3Y6.91%
Revenue Next 5Y6.64%
EBIT growth 1Y6.39%
EBIT growth 3Y-26.03%
EBIT growth 5Y-11.52%
EBIT Next Year183.79%
EBIT Next 3Y59.09%
EBIT Next 5YN/A
FCF growth 1Y127.16%
FCF growth 3YN/A
FCF growth 5Y-19.02%
OCF growth 1Y-18.57%
OCF growth 3Y30.97%
OCF growth 5Y-5.79%

STEPAN CO / SCL FAQ

What is the fundamental rating for SCL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCL.


Can you provide the valuation status for STEPAN CO?

ChartMill assigns a valuation rating of 3 / 10 to STEPAN CO (SCL). This can be considered as Overvalued.


Can you provide the profitability details for STEPAN CO?

STEPAN CO (SCL) has a profitability rating of 4 / 10.


What is the financial health of STEPAN CO (SCL) stock?

The financial health rating of STEPAN CO (SCL) is 3 / 10.


How sustainable is the dividend of STEPAN CO (SCL) stock?

The dividend rating of STEPAN CO (SCL) is 5 / 10 and the dividend payout ratio is 76.82%.